The use of soybean agglutinin (SBA) for bone marrow (BM) purging and hematopoietic progenitor cell enrichment in clinical bone-marrow transplantation

Applied Biochemistry and Biotechnology - Part B Molecular Biotechnology

Volumn 11, Issue 2, 1999, Pages 181-194

  Nagler, Arnon ^a   Morecki, Shoshana ^a   Slavin, Shimon ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Bone marrow transplantation; Hematopoietic progenitor cell; Soybean agglutinin

Indexed keywords

CD34 ANTIGEN; SOYBEAN AGGLUTININ;

ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOTRANSPLANTATION; BONE MARROW PURGING; BONE MARROW TRANSPLANTATION; BREAST CANCER; BURKITT LYMPHOMA; CELL FRACTIONATION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PROTEIN BINDING; REVIEW;

GLYCINE MAX;

EID: 0032775088     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02915811     Document Type: Review

References (77)

1. Georgiou, G. M., Roberton, D. M., Ellis, Wnm, Shen, B. J., Ekert, H., and Hosking, C. S. (1983) CFU-C enrichment from human bone marrow using a discontinous percoll gradient and soybean agglutinin in comparison with ficoll-hypaque. Clin. Exp. Immunol. 53, 491-496.
2. Reisner, Y., Ravid, A., and Sharon, N. (1976) Use of soybean agglutinin for the separation of mouse B and T lymphocytes. Biochem. Biophys. Res. Commun. 72, 1585-1591.
3. Reisner, Y., Itzicovitch, L., Meshorer, A., and Sharon, N. (1978) Hematopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins. Proc. Natl. Acad. Sci. USA 75, 2933-2936.
4. Reisner, Y., Ikehara, S., Hodes, M. Z., and Good, R. A (1980) Allogeneic hematopoietic stem cell transplantation using mouse spleen cells fractionated by lectins: In vitro study of cell fractions. Proc. Natl. Acad. Sci. USA 77, 1164-1168.
5. McMillan, A. K. and Goldstone, A. H. (1991) Autologous bone marrow transplantation of non Hodgkin's lymphoma. Eur. J. Haematol. 46, 129-135.
6. Vose, J. M. and Armitage, J. O. (1993) Role of ABMT in non-Hodgkin's lymphoma. Autologous bone marrow transplantation. Hematol. Oncol. Clin. North Am. 7, 577-590.
7. Freedman, A. S., Takvorian, T., Neuberg, D., Mauch, P., Rabinowe, S. N., Anderson, K. C., Soiffer, R. J., Spector, N., Grossbard, M., and Robertson, M. J. (1993) Autologous BMT in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: A pilot study. J. Clin. Oncol. 11, 931-936.
8. Freedman, A. and Nadler, L. M. (1992) BMT in low grade non-Hodgkin's lymphoma. Marrow Transplant Rev. 2, 33,34.
9. Philip, T., Armitage, J. O., Spitzer, G., Chauvin, F., Jagannath, S., Cahn, J. Y., Colombat, P., Goldstone, A. H., Gorin, N. C., Flesh, M., et al. (1987) High dose therapy and ABMT after failure of conventional chemotherapy in adults with intermediate grade or high grade non-Hodgkin's lymphoma. N. Engl. J. Med. 316, 1493-1499.
10. Chopra, R., McMillan, A. K., Linch, D. C., Yuklea, S., Taghipour, G., Pearce, R., Patterson, K. G., and Goldstone, A. H. (1993) The place of high dose BEAM therapy and ABMT in poor risk Hodgkin's disease: A single center eight year study of 155 patients. Blood 81, 1137-1145.
11. Vose, J. M., Bierman, P. J., and Armitage, J. O. (1990) Hodgkin's disease: The role of bone marrow transplantation. Semin. Oncol. 17, 749-757.
12. Peters, W. P., Ross, M., Vredenburgh, J., Meisenberg, B., Rosner, G., Marks, L., Mathias, B., Henderson, C., Hurd, D., Budman, D., Norton, L., and Weiss, R. B. (1992) High dose alkylating agents and ABMT for stage II/III breast cancer involving 10 or more axillary lymph nodes. Proc. Am. Soc. Clin. Oncol. 11, 58-65.
13. Meyers, S. E. and Williams, S. F. (1993) Role of high dose chemotherapy anti autologous stem cell support in treatment of breast cancer. Hematol. Oncol. Clin. North Am. 7, 631-645.
14. Slavin, S. and Nagler, A. (1991) New developments in bone marrow transplantation. Curr. Opinion Oncol. 3, 254-271.
15. Varadi, G. and Nagler, A. (1994) Conditioning regimens in autologous bone marrow transplantation. Clin. Immunother. 2, 342-351.
16. Brenner, M. K., Rill, D. R, Moen, R. C. Krance, R. A., Jr., J. M., Anderson, W. F., and Ihle, J. N. (1993) Gene marking to trace origin of relapse after autologous bone marrow transplantation. Lancet 341, 85,86.
17. Gribben, J. G., Freedman, A. S., Neuberg, D., Roy, D. C., Blake, K. W., Woo, S. D., Grossbard, M. L., Rabinowe, S. N., Coral, F., Freeman, G. J., et al. (1991) Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N. Engl. J. Med. 325, 1525-1533.
18. Young, J. L. and Miller, R. W. (1975) Incidence of malignant tumors in US children. J. Pediatr. 86, 254-258.
19. Evans, A. K., D'Angio, G. J., Propert, K., Anderson, J., and Hann, H. L. (1987) Prognostic factors in neuroblastoma. Cancer 59, 1853-1857.
20. Philip, T., Bernard, J. L., Zucker, J. M., Pinkerton, R., Lutz, P., Bordigoni, P., Plouvier, E., Robert, A., Carton, R., Philippe, N., et al. (1987) High dose chemotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: An unselected group of stage IV patients over 1 yr of age. J. Clin. Oncol. 5, 266-271.
21. Hartmann, O., Benhamou, E., Beaujeane, F., Kalifa, C., Lejars, O., Patte, C., Behard, C., Flamant, F., Thyss, A., Deville, A., et al. (1987) Repeated high dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma. J. Clin. Oncol. 5, 1205-1211.
22. Dini, G., Philip, T., Hartmann, O., Pinkerton, R., Chauvin, F., Garaventa, A., Lanino, E., and Dallorso, S. (1989) Bone marrow transplantation for neuroblastoma: A review of 509 cases. EBMT group. BAT 4 (Suppl. 4), 42-46.
23. Reisner, Y. (1983) Differential agglutination by soybean agglutinin of human leukemia and neuroblastoma cell lines: Potential application to autologous bone marrow transplantation. Proc. Natl. Acad. Sci. USA 80, 6657-6661.
24. Reisner, Y. and Gan, J. (1985) Differential binding of soybean agglutinin to human neuroblastoma cell lines: Potential application to autologous bone marrow transplantation. Cancer Res. 45, 4026-4031.
25. Kapelushnik, J., Nagler, A., Or, R., Naparstek, Cividali, G., Aker, M., Mehta, J., Mumcuoglu, M., and Slavin, S. (1993) Autologous bone marrow transplantation for stage IV neuroblastoma: The role of soybean agglutinin purging. Trans. Proc. 25, 2375-2376.
26. Bezwoda, W., Seymour, L., and Dansey, R. (1995) High dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: A randomized trial. J. Clin. Oncol. 13, 2483-2489.
27. Peters, W. P., Berry, D., Vredenburgh, J. J., Hussein, A., Rubin, P., Elkordy, M., Ross, M., Henderson, I. C., Budman, D., Norton, L., Weiss, R., and Hurd, D. (1995) Five year follow-up of high dose combination alkylating agents with ABMT as consolidation after standard dose CAF for primary breast cancer involving >10 axillary lymph nodes (Duke CALGB 8782). ASCO Proc. 933 (abstract).
28. Ayash, L., Wheeler, C., Fairclough, D., Schwartz, G., Reich, E., Warren, D., Schnipper, L., Antman, K., Frei, E., III, and Elias, A. (1995) Prognostic factors for prolonged progression free survival with high dose chemotherapy with autologous stem cell support for advanced breast cancer. J. Clin. Oncol. 13, 2043-2049.
29. Diel, J., Kaufmann, M., Goerner, R., Costa, S. D., Kaul, S., and Bastert, G. (1992) Detection of tumor cells in bone marrow of patients with primary breast cancer: A prognostic factor for distant metastasis. J. Clin. Oncol. 10, 1534-1539.
30. Cote, R. J., Rosen, P. P., Lesser, M. L. Old, L. J., Osborne, M. P. (1991) Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J. Clin. Oncol. 9, 1749-1756.
31. Ross, A. A., Cooper, B. W., Lazarus, H. M., Mackay, W., Moss, T. J., Ciobanu, N., Tallman, M. S., Kennedy, M. J., Davidson, N. E., Sweet, D., et al. (1993) Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 82, 2605-2610.
32. Fields, K., Elfenbein, G., Moscinski, L., Trudeau, W., and Janssen, W. (1995) PCR detection of breast cancer cells in peripheral blood stem cell collections: Incidence and correlations. Blood 86, 2474 (abstract).
33. Schulze, R., Schulze, M., Wischnik, A., Ehnle, S., Doukas, K., Behr, W., and Schlimok, G. (1995) Tumor cell contamination of peripheral blood stem cell transplants (PBSCT) and/or bone marrow (BM) in high risk breast cancer patients (N≥10). Blood 86, 923 (abstract).
34. Landys, K., Persson, S., Kovarik, J., Hultborn, R., and Holmberg, E. (1995) Prognostic value of bone marrow biopsy in operable breast cancer patients at the time of initial diagnosis: Results of a 19 year median follow-up. Eur. J. Cancer 31A(Suppl. 5), 647 (abstract).
35. Mansi, J. L., Berger, U., McDonnell, T., People, A., Rayter, Z., Gazet, J. C., and Coombes, R. C. (1989) The fate of bone marrow micrometastases in patients with primary breast cancer. J. Clin. Oncol. 7, 445-449.
36. Sharp, J., Kessinger, A., and Vaughan, W. (1992) Detection and clinical significance of minimal tumor contamination of peripheral blood stem cell harvests. J. Cell. Cloning 10(Suppl. 1), 92-94.
37. Ybanez, J., Lazarus, H., Ross, A., and Cooper, B. (1995) Impact of occult tumor (OT) reinfusion on outcome after high dose chemotherapy (HDC) in patients with advanced breast cancer. Blood 86, 1532 (abstract).
38. Shppall, E. J., Cagnoni, P., Gehling, U., Hami, L. S., and Hogan, C. J. (1995) Bone marrow purging, in High Dose Cancer Therapy, vol. 2 (Armitage, J. and Antman, K., eds.), Williams & Wilkens, Baltimore, MD, pp. 289-318.
39. Shppall, E., Jones, R., and Bast, R. (1991) 4-IIC purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high dose chemotherapy and autologous marrow support: A phase I trial. J. Clin. Oncol. 9, 85-93.
40. Coombes, R. and Buckman, R. A. F. (1986) In vitro and in vivo effects of monoclonal antibody toxin conjugate for patients with breast cancer. Cancer Res. 50, 1170-1175.
41. Lebkowski, J. S., Schain, L. R., Okrongly, D., Levinsky, R., Harvey, J. M. J., and Okarma, T. B. (1992) Rapid isolation of human CD34 hematopoietic stem cells purging of human tumor cells. Transplantation 53, 1011-1019.
42. + peripheral blood progenitor cells in breast cancer patients: Monitoring of purging efficiency by cytokeralin 19 and EGF-R based RT-PCR. Blood 86, 922 (abstract).
43. Thomas, T. E., Zant, G. V., Phillips, G. L., and Lansdorp, P. M. (1995) Simultaneous direct purging of breast carcinoma cells and enrichment of CD 34+ cells using one step high gradient magnetic cell depletion. Blood 86, 2485 (abstract).
44. Passos-Coelho Ross, A. A., Davis, J. M., Huelskamp, A. M., Clarke, B., Noga, S. J., Davidson, N. E., and Kennedy, M. J. (1994) Bone marrow micrometastases in chemotherapy responsive advanced breast cancer: Effect of ex vivo purging with 4-hydroperoxycyl-clophosphamide. Cancer Res. 54, 7366-7371.
45. Mklebust, A. T., Godal, A., Juell, S., Pharo, A., and Fodstad, O. (1994) Comparison of two antibody based methods for elimination of breast cancer cells from human bone marrow. Cancer Res. 54, 909-214.
46. Morecki, S., Pavlotzky, F., Margel, S., and Slavin, S. (1987) Purging breast cancer cells in preparation for autologous bone marrow transplantation. Bone Marrow Transplant. 1, 357-363.
47. Morecki, S., Margel, S., and Slavin, S. (1988) Removal of breast cancer cells by soybean agglutinin in an experimental model for purging human marrow. Cancer Res. 48, 4573-1577.
48. Morecki, S. and Slavin, S. (1988) Combination of magnetic and chemocytotoxic cancer cell depletion for autologous bone marrow transplantation. Israel J. Med. Sci. 24, 488-493.
49. Philip, I., Favort, M. C., and Philip, T (1985) Detection of Burkitt's cells in remission marrow by a cell culture monitoring system implications for autologous bone marrow transplantation, in Autologous Bone Marrow Transplant: Proceedings of the First International Symposium (Dicke, K. A., Spitzer, G., and Zander, A. R., eds.), University of Texas M.D. Anderson Hospital and Tumor Institute, Houston, TX, p. 341.
50. Favrot, M. C., Philip, I., Philip, T., Protoukalian, J., Dore, J. F., and Lenoir, G. M. (1984) Distinct reactivity of Burkitt's lymphoma cell lines with eight monoclonal antibodies correlated with the ethnic origin. J. Natl. Cancer Inst. 73, 841-847.
51. Momcuoglu, M., Favort, M., and Slavin, S. (1990) Lectin binding properties of Burkitt's lymphoma cell lines: Application to bone marrow purging. Exp. Hematol. 18, 55-60.
52. Marmont, A. M., Gale, R. P., Butturini, A., Goldman, J. M.: Martelli, M. F., Prentice, H. G., Slavin, S., Storb, R., Truitt, R. L., and Van Bekkum, D. W. (1989) T cell depletion in allogeneic bone marrow transplantation progress and problems. Hematologia 74, 235-248.
53. Reisner, Y., Kapoor, N., Kirkpatrick, D., Pollack, M. S., Cunningham-Rundles, S., Dupont, B., Hodes, M. Z., Good, R. A., and O'Reilly, R. J. (1983) Transplantation for severe combined immunodeficiency with HLA, A, B, DR incompatible parent marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 61, 341-348.
54. Reisner, Y., Kapoor, N., Kirkpatrick, D., Pollack, M. S., Dupont, B., Good, R. A., and O'Reilly, R. J. (1981) Transplantation for acure leukemia with HLA A and B nonidentical parent marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet 2, 327-331.
55. Reisner, Y., Pahwa, S., Chiao, J. W., Sharon, N., Evans, R. L., and Good, R. A. (1980) Separation of antibody helper and antibody suppressor human T-cells by using soybean agglutinin. Proc. Natl. Acad. Sci. USA 77, 6778-6782.
56. Morecki, S., Weigensberg, M., and Slavin, S. (1985) Lectin separation of nonlymphoid suppressor cells induced by lymphoid irradiation. Eur. J. Immunol. 15, 138-148.
57. Slocombe, G. W., Newland, A. C., Yeatman, N. W., Nacey, M., Jones, H. M., and Knott, L. (1986) Allogeneic bone marrow transplantation for adult leukaemia with soybean lectin fractionated marrow. Bone Marrow Transplant. 1, 31-39.
58. Frame, J. N., Collins, N. H., Cartagena, T., Waldmann, H., O'Reilly, R. J., Dupont, B., and Kernan, N. A. (1989) T-cell depletion of human bone marrow. Comparison of Campath-1 plus complement. Anti-T-cell ricin, A chain immunotoxin, and soybean agglutinin alone or in combination with sheep erythrocytes or immunomagnetic beads. Transplantation 47, 984-988.
59. Keever, C. A., Welte, K., Sullivan, M., and O'Reilly, R. J. (1987) Phenotype and functional characterization of NK and LAK cells following T depleted bone marrow transplantation. Prog. Clin. Biol. Res. 244, 423-432.
60. Keever, C. A., Welte, K., Small, T., Levick, J., Sullivan, M., Hauch, M., Evans, R. L., and O'Reilly, R. J. (1987) Interleukin 2 activated killer cells in patients following transplants of soybean lectin separated and E-rosette depleted bone marrow. Blood 70, 1893-1903.
61. Welte, K., Keever, C. A., Levick, J., Bonilla, M. A., Merluzzi, V. J., Mertelsmann, R., Evans, R., and O'Reilly, R. J. (1987) Interleukin 2 production and response to interleukin-2 by peripheral blood mononuclear cells from patients after bone marrow transplantation: II. Patients receiving soybean lectin separated and T-cell depleted bone marrow. Blood 70, 1595-1603.
62. Friedrich, W., Goldmann, S. F., Vette, U., Fliedner, T. M., Heymer, B., Peter, H. H., Reisner, Y., and Kleihauer, E. (1984) Immunoreconstitution in severe combined immunodeficiency after transplantation of HLA-haploidentical, T-cell depleted bone marrow. Lancet 1(8380), 761-764.
63. Minegishi, M., Tsuchiya, S., Imaizumi, M., Yamaguchi, Y., Goto, Y., Tamura, M., Konno, T., and Tada, K. (1985) Successful transplantation of soybean agglutinin fractionated, histoincompatible, maternal marrow in a patient with severe combined immunodeficiency anal BCG infection. Eur. J. Pediatr. 143, 291-294.
64. Nespoli, L., Porta, F., Locatelli, F., Aversa, F., Carotti, A., Lanfranchi, A., Gibardi, A., Marchesi, M. E., Abate, L., Martelli, M. F., et al. (1990) Successful lectin separated bone marrow transplantation in adenosine deaminase deficiency related severe immunodeficiency. Hematologica 75, 546-550.
65. Cowan, M. J., Wara, D. W., Weintrub, P. S., Pabst, H., Ammann, A. J. (1985) Haploidentical bone marrow transplantation for severe combined immunodeficiency disease using soybean agglutinin-negative, T depleted marrow cells. Clin. Immunol. 5, 370-376.
66. Averssa, F., Tabilio, A., Terenzi, A., Velardi, A., Falzetti, F., Giannoni, C., Iacucci, R., Zei, T., Martelli, M. P., Gambelunghe, C., et al. (1994) Successful engraftment of T-cell depleted haploidentical "three loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony stimulating factor mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 84, 3394-3955.
67. Berenson, R. J., Andrews, R. G., Bensinger, W. I., Kalamasz, D., and Knitter, G. (1988) Antigen CD34+ marrow cells engraft lethally irradiated baboons. J. Clin. Invest. 81, 951-955.
68. Reisner, Y., Kapoor, N., Hodes, M. Z., O'Reilly, R. J., and Good, R. A. (1982) Enrichment for CFU-C from murine and human marrow using soybean agglutination. Blood 59, 360-363.
69. Ebell, W., Castro-Malaspina, H., Moore, M., and O'Reilly, R. J. (1985) Depletion of stromal elements in human marrow grafts separated by soybean agglutinin. Blood 65, 1105-1111.
70. Andrews, R. G., Singer, J. W., Bernstein, I. D. (1986) Monoclonal antibody 12-8 recognizes a 115 Kd molecule present on both unipotent and multipotent hematopoietic differentiation antigens. Blood 67, 842-845.
71. Civin, C. I., Strauss, L. C., Brovall, C., Fackler, M. J. Schwartz, J. F., and Shaper, J. H. (1984) A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-la cells. J. Immunol. 133, 157-165.
72. Watt, S. M., Karhi, K., Gatter, K., Furley, A. J. W., Katz, F. E., Healy, L. E., Atlass, L. J., Bradley, N. J., Sutherland, D. R., Levinsky, R., and Greaves, M. F. (1987) Distribution and epitope analysis of the cell membrane glyco-protein (HPCA-I) associated with human hematopoietic progenitor cells. Leukemia 1, 417-426.
73. Varadi, G., Elchalal, U., Brautbar, C., and Nagler, A. (1995) Human umbilical cord blood for hematopoietic progenitor cells transplantation. Leukemia Lymphoma 20, 51-58.
74. Broxmeyer, H. E., Douglas, G. W., Hangoc, G., Cooper, S., Brad, J., English, D., Arny, M., Thomas, L., and Boyse, E. A. (1989) Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc. Natl. Acad. Sci. USA 86, 3828-3832.
75. Thierry, D., Traineau, R., Adam, M., Delachaux, V., Brossard, Y., Richard, P., Gerotta, A., Devergie, A., Benbuman, M., and Gluckman, E. (1990) Hematopoietic stem cell potential from umbilical cord blood. Nouv. Rev. Fr. Hematol. 32, 439,440.
76. Wagner, J. E. (1993) Umbilical cord blood stem cell transplantation. Am J. Ped. Hematol/Oncol. 15, 169-174.
77. Nagler, A., Peacock, M., Tantoco, M., Lamons, D., Okarma, T. B., and Okrongly, D. A. (1994) Real blood cell depletion and enrichment of CD34+ hematopoietic progenitor cells from human umbilical cord blood using soybean agglutinin and CD34+ immunoselection. Exp. Hematol. 22, 1134-1140.